Sequential therapy of neoadjuvant biochemotherapy with cetuximab, paclitaxel, and cisplatin followed by cetuximab‐based concurrent bioradiotherapy in high‐risk locally advanced oral squamous cell carcinoma: Final analysis of a phase 2 clinical trial-Reference-Cited by-同舟云学术

Sequential therapy of neoadjuvant biochemotherapy with cetuximab, paclitaxel, and cisplatin followed by cetuximab‐based concurrent bioradiotherapy in high‐risk locally advanced oral squamous cell carcinoma: Final analysis of a phase 2 clinical trial

Published:2019-01-12 Issue:6 Volume:41 Page:1703-1712
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head & Neck

Author:

Yen Chia‐Jui¹,Tsou Hsiao‐Hui²³,Hsieh Ching‐Yun⁴,Chu Chang‐Yao⁵,Chiu Chang‐Fang⁴,Chen Chih‐Cheng⁶,Tsao Chao‐Jung⁷,Tsai Kuo‐Yang⁸,Tsai Sen‐Tien⁹,Chang Jang‐Yang¹¹⁰,Chang Kwang‐Yu¹¹⁰^ORCID

Affiliation:

1. Division of Hematology/Oncology, Department of Internal MedicineNational Cheng Kung University Hospital, College of Medicine, National Cheng Kung University Tainan Taiwan

2. Institute of Population Health Sciences, National Health Research Institutes Miaoli Taiwan

3. Graduate Institute of BiostatisticsCollege of Public Health, China Medical University Taichung Taiwan

4. Division of Hematology and Oncology, Department of Internal MedicineChina Medical University Hospital Taichung Taiwan

5. Department of PathologyNational Cheng Kung University Hospital, College of Medicine, National Cheng Kung University Tainan Taiwan

6. Department of Hematology and OncologyChang Gung Memorial Hospital at Chiayi Chiayi Taiwan

7. Division of Hematology and Oncology, Department of Internal MedicineChi‐Mei Medical Center Tainan Taiwan

8. Department of Oral and Maxillofacial SurgeryChanghua Christian Hospital Changhua Taiwan

9. Department of OtolaryngologyNational Cheng Kung University Hospital, College of Medicine, National Cheng Kung University Tainan Taiwan

10. National Institute of Cancer Research, National Health Research Institutes Tainan Taiwan

Funder

National Health Research Institutes

Publisher

Wiley

Subject

Otorhinolaryngology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hed.25640

Reference54 articles.

1. Global cancer statistics

2. A review of human carcinogens—Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish

3. Head and Neck Cancer

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosomal miR-146b-5p derived from cancer-associated fibroblasts promotes progression of oral squamous cell carcinoma by downregulating HIPK3;Cellular Signalling;2023-06

2. A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma;Nature Communications;2022-09-14

3. The nanocomposite system comprising folic acid-modified graphene quantum dots loaded with evodiamine in the treatment of oral squamous cell carcinoma;Materials & Design;2022-08

4. Prognostic significance of CircRNAs expression in oral squamous cell carcinoma;Oral Diseases;2022-03-27

5. Bleeding complications and possible resistance patterns of anti-angiogenesis treatments in recurrent/metastatic head-and-neck squamous cell carcinoma – Reflections from a phase II study of pazopanib in recurrent/metastatic head-and-neck squamous cell carcinoma;Journal of Cancer Research and Practice;2022